Biochemical and structural analysis of the binding determinants of a vascular endothelial growth factor receptor peptidic antagonist

Journal of Medicinal Chemistry

Volumn 53, Issue 11, 2010, Pages 4428-4440

  Gautier, Benoit ^a   Goncalves, Victor ^a   Diana, Donatella ^b   Di Stasi, Rossella ^c   Teillet, Florence ^a   Lenoir, Christine ^a   Huguenot, Florent ^a   Garbay, Christiane ^a   Fattorusso, Roberto ^b   D'Andrea, Luca Domenico ^c   Vidal, Michel ^a   Inguimbert, Nicolas ^a,d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c CNR   (Italy)

^d UNIVERSITÉ DE PERPIGNAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYCLOPEPTIDE; IMMUNOGLOBULIN; LIGAND; MACROCYCLIC COMPOUND; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RECEPTOR BLOCKING AGENT; TUBULIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ANTAGONIST; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DERIVATIZATION; DRUG BINDING SITE; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MOLECULAR PROBE; PROTEIN DOMAIN; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS;

EID: 77953180975     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm1002167     Document Type: Article

References (55)

1. Ferrara, N.; Kerbel, R. S. Angiogenesis as a therapeutic target Nature 2005, 438, 967-974
2. Carmeliet, P.; Jain, R. K. Angiogenesis in cancer and other diseases Nature 2000, 407, 249-257
3. Takahashi, H.; Shibuya, M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions Clin. Sci. (London) 2005, 109, 227-241
4. Carmeliet, P. Angiogenesis in life, disease and medicine Nature 2005, 438, 932-936
5. Folkman, J. Tumor angiogenesis: therapeutic implications N. Engl. J. Med. 1971, 285, 1182-1186
6. Jain, R. K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 2005, 307, 58-62
7. Shinkaruk, S.; Bayle, M.; Lain, G.; Deleris, G. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy Curr. Med. Chem. Anticancer Agents 2003, 3, 95-117
8. Ellis, L. M.; Hicklin, D. J. VEGF-targeted therapy: mechanisms of anti-tumour activity Nat. Rev. Cancer 2008, 8, 579-591
9. Ferrara, N.; Gerber, H. P.; LeCouter, J. The biology of VEGF and its receptors Nat. Med. 2003, 9, 669-676
10. Roskoski, R., Jr. Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit. Rev. Oncol. Hematol. 2007.
11. De Paepe, B. Anti-angiogenic agents and cancer: current insights and future perspectives Recent Pat. Anticancer Drug Discovery 2009, 4, 180-185
12. Ferrara, N.; Hillan, K. J.; Novotny, W. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy Biochem. Biophys. Res. Commun. 2005, 333, 328-335
13. Ferrara, N.; Mass, R. D.; Campa, C.; Kim, R. Targeting VEGF-A to treat cancer and age-related macular degeneration Annu. Rev. Med. 2007, 58, 491-504
14. Lau, S. C.; Rosa, D. D.; Jayson, G. Technology evaluation: VEGF Trap (cancer), Regeneron/sanofi-aventis Curr. Opin. Mol. Ther. 2005, 7, 493-501
15. Gerber, D. Targeted therapies: a new generation of cancer treatments Am. Acad. Family Physicians 2008, 77, 311-319
16. Wilhelm, S. M.; Adnane, L.; Newell, P.; Villanueva, A.; Llovet, J. M.; Lynch, M. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling Mol. Cancer Ther. 2008, 7, 3129-3140
17. Faivre, S.; Demetri, G.; Sargent, W.; Raymond, E. Molecular basis for sunitinib efficacy and future clinical development Nat. Rev. Drug Discovery 2007, 6, 734-745
18. Posey, J. A.; Ng, T. C.; Yang, B.; Khazaeli, M. B.; Carpenter, M. D.; Fox, F.; Needle, M.; Waksal, H.; LoBuglio, A. F. A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma Clin. Cancer Res. 2003, 9, 1323-1332
19. DeLano, W. L. Unraveling hot spots in binding interfaces: progress and challenges Curr. Opin. Struct. Biol. 2002, 12, 14-20
20. Veslovsky, A. V.; Archakov, A. I. Inhibitors of protein-protein interaction as potential drugs Curr. Comput.-Aided Drug Des. 2007, 3, 51-58
21. D'Andrea, L. D.; Del Gatto, A.; De Rosa, L.; Romanelli, A.; Pedone, C. Peptides targeting angiogenesis related growth factor receptors Curr. Pharm. Des. 2009, 15, 2414-2429
22. Goncalves, V.; Gautier, B.; Garbay, C.; Vidal, M.; Inguimbert, N. Structure-based design of a bicyclic peptide antagonist of the vascular endothelial growth factor receptors. J. Pept. Sci. 2007.
23. Goncalves, V.; Gautier, B.; Coric, P.; Bouaziz, S.; Lenoir, C.; Garbay, C.; Vidal, M.; Inguimbert, N. Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor J. Med. Chem. 2007, 50, 5135-5146
24. Goncalves, V.; Gautier, B.; Regazzetti, A.; Coric, P.; Bouaziz, S.; Garbay, C.; Vidal, M.; Inguimbert, N. On-resin cyclization of peptide ligands of the vascular endothelial growth factor receptor 1 by copper(I)-catalyzed 1,3-dipolar azide-alkyne cycloaddition Bioorg. Med. Chem. Lett. 2007, 17, 5590-5594
25. Wiesmann, C.; Fuh, G.; Christinger, H. W.; Eigenbrot, C.; Wells, J. A.; de Vos, A. M. Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor Cell 1997, 91, 695-704
26. Christinger, H. W.; Fuh, G.; de Vos, A. M.; Wiesmann, C. The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1 J. Biol. Chem. 2004, 279, 10382-10388
27. Keyt, B. A.; Nguyen, H. V.; Berleau, L. T.; Duarte, C. M.; Park, J.; Chen, H.; Ferrara, N. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis J. Biol. Chem. 1996, 271, 5638-5646
28. Muller, Y. A.; Li, B.; Christinger, H. W.; Wells, J. A.; Cunningham, B. C.; de Vos, A. M. Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 7192-7197
29. Li, B.; Fuh, G.; Meng, G.; Xin, X.; Gerritsen, M. E.; Cunningham, B.; de Vos, A. M. Receptor-selective variants of human vascular endothelial growth factor. Generation and characterization J. Biol. Chem. 2000, 275, 29823-29828
30. Errico, M.; Riccioni, T.; Iyer, S.; Pisano, C.; Acharya, K. R.; Persico, M. G.; De Falco, S. Identification of placenta growth factor determinants for binding and activation of Flt-1 receptor J. Biol. Chem. 2004, 279, 43929-43939
31. Goncalves, V. G., B.; Lenoir, C.; Garbay, C.; Vidal, M.; Inguimbert, N. Peptides as antagonists of the VEGF receptors PharmaChem 2006, 15-19
32. Goncalves, V.; Gautier, B.; Garbay, C.; Vidal, M.; Inguimbert, N. Development of a chemiluminescent screening assay for detection of vascular endothelial growth factor receptor 1 ligands Anal. Biochem. 2007, 366, 108-110
33. Gautier, B.; Goncalves, V.; Huguenot, F.; Garbay, C.; Vidal, M.; Inguimbert, N. unpublished results.
34. Olsson, A. K.; Dimberg, A.; Kreuger, J.; Claesson-Welsh, L. VEGF receptor signalling-in control of vascular function Nat. Rev. Mol. Cell Biol. 2006, 7, 359-371
35. Chang, C. D.; Meienhofer, J. Solid-phase peptide-synthesis using mild base cleavage of nalpha-fluorenylmethyloxycarbonylamino acids, exemplified by a synthesis of dihydrosomatostatin Int. J. Pept. Protein Res. 1978, 11, 246-249
36. Kates, S. A.; Sole, N. A.; Johnson, C. R.; Hudson, D.; Barany, G.; Albericio, F. A. A novel, convenient, three-dimensional orthogonal strategy for solid-phase synthesis of cyclic peptides Tetrahedron. Lett. 1993, 34, 1549-1552
37. Johnson, T.; Liley, M. J.; Cheeseright, T. J.; Begum, F. Problems in the synthesis of cyclic peptides through use of the Dmab protecting group J. Chem. Soc., Perkin Trans. 2000, 43, 2811-2820
38. Starzec, A.; Ladam, P.; Vassy, R.; Badache, S.; Bouchemal, N.; Navaza, A.; du Penhoat, C. H.; Perret, G. Y. Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex Peptides 2007, 28, 2397-2402
39. Yongye, A. B.; Li, Y.; Giulianotti, M. A.; Yu, Y.; Houghten, R. A.; Martinez-Mayorga, K. Modeling of peptides containing D-amino acids: implications on cyclization J. Comput.-Aided Mol. Des. 2009, 23, 677-689
40. Goncalves, V.; Gautier, B.; Huguenot, F.; Leproux, P.; Garbay, C.; Vidal, M.; Inguimbert, N. Total chemical synthesis of the D2 domain of human VEGF receptor 1 J. Pept. Sci. 2009, 15, 417-422
41. Chamorro, C.; Kruijtzer, J. A.; Farsaraki, M.; Balzarini, J.; Liskamp, R. M. A general approach for the non-stop solid phase synthesis of TAC-scaffolded loops towards protein mimics containing discontinuous epitopes Chem. Commun. (Camb.) 2009, 821-823
42. Barleon, B.; Totzke, F.; Herzog, C.; Blanke, S.; Kremmer, E.; Siemeister, G.; Marme, D.; Martiny-Baron, G. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1 J. Biol. Chem. 1997, 272, 10382-10388
43. Lacal, P. M.; Morea, V.; Ruffini, F.; Orecchia, A.; Dorio, A. S.; Failla, C. M.; Soro, S.; Tentori, L.; Zambruno, G.; Graziani, G.; Tramontano, A.; D'Atri, S. Inhibition of endothelial cell migration and angiogenesis by a vascular endothelial growth factor receptor-1 derived peptide Eur. J. Cancer 2008, 44, 1914-1921
44. Starovasnik, M. A.; Christinger, H. W.; Wiesmann, C.; Champe, M. A.; de Vos, A. M.; Skelton, N. J. Solution structure of the VEGF-binding domain of Flt-1: comparison of its free and bound states J. Mol. Biol. 1999, 293, 531-544
45. Leppanen, V. M.; Prota, A. E.; Jeltsch, M.; Anisimov, A.; Kalkkinen, N.; Strandin, T.; Lankinen, H.; Goldman, A.; Ballmer-Hofer, K.; Alitalo, K. Structural determinants of growth factor binding and specificity by VEGF receptor 2 Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 2425-2430
46. Millauer, B.; Wizigmann-Voos, S.; Schnurch, H.; Martinez, R.; Moller, N. P.; Risau, W.; Ullrich, A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis Cell 1993, 72, 835-846
47. Bernatchez, P. N.; Soker, S.; Sirois, M. G. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent J. Biol. Chem. 1999, 274, 31047-31054
48. Waltenberger, J.; Claesson-Welsh, L.; Siegbahn, A.; Shibuya, M.; Heldin, C. H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor J. Biol. Chem. 1994, 269, 26988-26995
49. Gille, H.; Kowalski, J.; Yu, L.; Chen, H.; Pisabarro, M. T.; Davis-Smyth, T.; Ferrara, N. A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration Embo J. 2000, 19, 4064-4073
50. Fuh, G.; Wu, P.; Liang, W. C.; Ultsch, M.; Lee, C. V.; Moffat, B.; Wiesmann, C. Structure-function studies of two synthetic anti-vascular endothelial growth factor Fabs and comparison with the Avastin Fab J. Biol. Chem. 2006, 281, 6625-6631
51. Vidal, M.; Liu, W. Q.; Lenoir, C.; Salzmann, J.; Gresh, N.; Garbay, C. Design of peptoid analogue dimers and measure of their affinity for Grb2 SH3 domains Biochemistry 2004, 43, 7336-7344
52. Hajduk, P. J.; Meadows, R. P.; Fesik, S. W. NMR-based screening in drug discovery Q. Rev. Biophys. 1999, 32, 211-240
53. Keller, R. The Computer Aided Resonance Assignment Tutorial; CANTINA Verlag: Goldau, 2004.
54. Garrett, D. S.; Seok, Y. J.; Peterkofsky, A.; Clore, G. M.; Gronenborn, A. M. Identification by NMR of the binding surface for the histidine-containing phosphocarrier protein HPr on the N-terminal domain of enzyme I of the Escherichia coli phosphotransferase system Biochemistry 1997, 36, 4393-4398
55. Koradi, R.; Billeter, M.; Wuthrich, K. MOLMOL: a program for display and analysis of macromolecular structures J. Mol. Graph. 1996, 14 (51-55) 29-32